Category: Pharmaceuticals
Oceania Pharmaceuticals
-
Asia-pacific Dry Eye Disease Market Forecast (2024-2032)
... $1216.91 million in 2023, reaching a revenue of $1987.33 million by 2032. MARKET INSIGHTS Factors such as the increasing prevalence of dry eye disease and a rising demand for dry eye disease treatment products are ... Read More
-
Asia Pacific Blood Glucose Monitoring Market Research Report Information, By Product Type (Invasive Glucose Monitoring, Flash Glucose Monitoring, and CGM), By Application (Type 1 Diabetes, and Type 2 Diabetes), By End-User (Diagnostics Center, Hospitals, and Clinics), And, By Region (Asia-Pacific) –Industry Forecast till 2032
... Clinics), And, By Region (Asia-Pacific) –Industry Forecast till 2032 The Asia Pacific Blood Glucose Monitoring Market was valued at USD 1.1 billion in 2022. The Asia Pacific Blood Glucose Monitoring market is expected to increase ... Read More
-
Asia Pacific Assistive Robots Market: Market Size, Forecast, Insights, and Competitive Landscape
... assistive robot market provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the Asia Pacific assistive robot by categorising the market ... Read More
-
Asia Pacific BPO Services Market: Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 9.0% during 2025-2034. This report on Asia Pacific BPO services market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of ... Read More
-
Asia Pacific Bioprocessing Market Forecast to 2031 - Regional Analysis - by Product (Instruments and Consumables & Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others)
... Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others) The Asia Pacific bioprocessing market was valued at US$ 5,488.87 million in 2023 and is expected ... Read More
-
Opioid Use Disorder (OUD) Market Size, Share, and Analysis, By Drug Class (Buprenorphine, Methadone, and Naltrexone), By Route of Administration (Oral, Sublingual, and Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
... Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034 Opioid Use Disorder (OUD) Market Size, Share, and Analysis, By Drug Class (Buprenorphine, Methadone, and Naltrexone), By Route of Administration (Oral, ... Read More
-
Australia and New Zealand Nutritional Supplements Market (Powder, Tablets, Capsules, Liquid, Soft Gels, Others); By Product Type (Sports Nutrition, Dietary Supplements, Fat Burner, Functional Food, Others); By Age Group (Kids, Adults, Geriatric); By Distribution Channel (Supermarkets/Hypermarkets, Specialty Stores, Pharmacies, E-commerce, Others), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... (Supermarkets/Hypermarkets, Specialty Stores, Pharmacies, E-commerce, Others), Trend Analysis, Competitive Landscape & Forecast, 2019–2030 Australia & New Zealand Nutritional Supplements Market Booming to Surpass USD 9.7 Billion by 2030 Australia & New Zealand Nutritional Supplements Market ... Read More
-
Consumer Health in Australia
... suffering, as some consumers are also being forced to reduce spending on essentials such as groceries to keep up with bills and debts. In general, consumer health is a resilient industry. Categories such as analgesics ... Read More
-
Sleep Aids in Australia
... remains evident in Australia with many, particularly consumers aged 18-30 years, seeking help for anxiety, poor sleep quality and unhealthy sleep habits. In addition, the review period has seen surging inflation rates, higher interest rates, ... Read More
-
Dietary Supplements in Australia
... be attributable partly to price-driven growth, dietary supplements continues to grow in retail volume terms across much of the category. This highlights that spending on dietary supplements has been maintained amidst a difficult economic climate ... Read More
-
Analgesics in Australia
... 2023, the TGA has given manufacturers and retailers until February 2025 to adjust to the new measures, which have been driven by the need for a harm reduction approach to curb the high rates of ... Read More
-
Paediatric Consumer Health in Australia
... products, the move has impacted chewable tablet formats. Announced by the TGA in May 2023, the new restrictions on acetaminophen include: reducing the maximum size of packs available for general sale (such as through supermarkets ... Read More
-
Digestive Remedies in Australia
... impacted consumer spending – in conjunction with higher interest rates and the rapid rise in the cost of living. Consumer Price Index (CPI) indicators reveal that spending on health, including pharmaceuticals, rose by 5.3% year-on-year ... Read More
-
Dermatologicals in Australia
... February 2024), skin conditions (including skin rashes, eczema and psoriasis) had a moderate to severe impact on everyday life for 49% of respondents in Australia, the highest rate on record since tracking began in 2019 ... Read More
-
NRT Smoking Cessation Aids in Australia
... Institute of Health and Welfare’s National Drug Strategy Household Survey 2022-2023, fewer than 10% of people in Australia over 14 years of age smoked daily, while the use of e-vapour products tripled between 2019 and ... Read More
-
Vitamins in Australia
... Australian consumers and those who are able to spend additional money on maintaining their general wellbeing through supplementation are willing to do so despite recent price increases. While single vitamins holds higher value share, multivitamins ... Read More
-
Cough, Cold and Allergy (Hay Fever) Remedies in Australia
... September. While there was a concerning early start to the flu season in 2024, with unseasonably high rates of influenza and respiratory syncytial virus (RSV), as well as the nation’s first surge in whooping cough ... Read More
-
Asia Pacific Biopharma Excipients Market Size, Share & Trends Analysis Report By Product (Solubilizers & Surfactants/Emulsifiers, Polyols, Carbohydrates, Specialty Biopharma Excipients), By Country, And Segment Forecasts, 2024 - 2030
... & Trends The Asia Pacific biopharma excipient market size is expected to reach USD 1.1 billion in 2030 and is projected to grow at a CAGR of 5.8% from 2024 to 2030. Patent expiry of ... Read More
-
Clinical Trial Biorepository & Archiving Solutions Market Size, Share, Trends, Industry Analysis Report: By Product (Preclinical Products and Clinical Products), By Service, By Phase, and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2024–2032
... Middle East & Africa) – Market Forecast, 2024–2032 The global clinical trial biorepository & archiving solutions market size is expected to reach USD 8.09 billion by 2032, according to a new study by Polaris Market ... Read More
-
Organoids Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity and Efficacy Testing, Drug Discovery and Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), Offering (Instruments, Consumables, and Services), Method (Micropatterned Plates, Ultralow Attachment Plates, Hanging Drop, Microdroplet/Emulsion, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... of Infectious Disease, Regenerative Medicine, Drug Toxicity and Efficacy Testing, Drug Discovery and Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), Offering (Instruments, Consumables, and Services), Method (Micropatterned Plates, ... Read More
-
Herbal/Traditional Products in New Zealand
... addition to retail volume growth, some of this value growth is due to continued price rises as a result of inflationary pressures and rising costs, although price rises are starting to slow. Euromonitor International's Herbal/Traditional ... Read More
-
Consumer Health in New Zealand
... Zealand in the years since COVID-19 first hit the country’s shores. With international and domestic supply chains severely disrupted as demand returned at pace following the removal of movement and travel restrictions, a consequence of ... Read More
-
NRT Smoking Cessation Aids in New Zealand
... year. While volume sales are being limited by falling smoking prevalence and the use of other methods to help quit smoking, value sales growth within the category are being strongly influenced by unit price growth, ... Read More
-
Digestive Remedies in New Zealand
... Zealand population, and this has also been exacerbated by the cost of living pressures faced by consumers. A high proportion of consumers do not eat the recommended number of servings of fruit and vegetables, and ... Read More
-
Analgesics in New Zealand
... levels of social interaction, which meant that incidences of seasonal cold and flu reduced year-over-year, which should have had a negative impact on sales of analgesics. Nevertheless, demand was instead driven by demand to relieve ... Read More
Research Assistance
